AEterna Zentaris Inc. (AEZS)

[at14tao]

You'll be waiting a while for that price and if it makes it there, AEZS won't be worth buying because it will mean phase 3 failure, continued NASDAQ listing issue, possible reverse split, more dilution guaranteed and possibly the end of AEZS. $2.00 - $2.50 is more realistic for this amount of dilution but with results of phase 3 trials coming this year it's probably going to hold it up until then.